Correlation Between Esperion Therapeutics and Innate Pharma
Can any of the company-specific risk be diversified away by investing in both Esperion Therapeutics and Innate Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Esperion Therapeutics and Innate Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Esperion Therapeutics and Innate Pharma, you can compare the effects of market volatilities on Esperion Therapeutics and Innate Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Esperion Therapeutics with a short position of Innate Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Esperion Therapeutics and Innate Pharma.
Diversification Opportunities for Esperion Therapeutics and Innate Pharma
-0.83 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Esperion and Innate is -0.83. Overlapping area represents the amount of risk that can be diversified away by holding Esperion Therapeutics and Innate Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innate Pharma and Esperion Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Esperion Therapeutics are associated (or correlated) with Innate Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innate Pharma has no effect on the direction of Esperion Therapeutics i.e., Esperion Therapeutics and Innate Pharma go up and down completely randomly.
Pair Corralation between Esperion Therapeutics and Innate Pharma
Given the investment horizon of 90 days Esperion Therapeutics is expected to generate 0.81 times more return on investment than Innate Pharma. However, Esperion Therapeutics is 1.23 times less risky than Innate Pharma. It trades about 0.2 of its potential returns per unit of risk. Innate Pharma is currently generating about -0.13 per unit of risk. If you would invest 196.00 in Esperion Therapeutics on September 3, 2024 and sell it today you would earn a total of 84.00 from holding Esperion Therapeutics or generate 42.86% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Esperion Therapeutics vs. Innate Pharma
Performance |
| Timeline |
| Esperion Therapeutics |
| Innate Pharma |
Esperion Therapeutics and Innate Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Esperion Therapeutics and Innate Pharma
The main advantage of trading using opposite Esperion Therapeutics and Innate Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Esperion Therapeutics position performs unexpectedly, Innate Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innate Pharma will offset losses from the drop in Innate Pharma's long position.| Esperion Therapeutics vs. Elanco Animal Health | Esperion Therapeutics vs. SIGA Technologies | Esperion Therapeutics vs. Catalent | Esperion Therapeutics vs. ANI Pharmaceuticals |
| Innate Pharma vs. Eliem Therapeutics | Innate Pharma vs. HCW Biologics | Innate Pharma vs. Inhibrx | Innate Pharma vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |